Persistent M&A Risks Will Challenge Digital Health Resilience
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 14 Analysts
Published
11 Jul 25
Updated
16 Aug 25
AnalystLowTarget's Fair Value
CA$5.60
14.7% undervalued intrinsic discount16 Aug
CA$4.78
1Y
2.8%7D
-0.6%